Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-249,571
Closed -$3.85M 33
2023
Q3
$3.85M Buy
249,571
+83,674
+50% +$1.4M 1.23% 27
2023
Q2
$3.14M Buy
165,897
+8,672
+6% +$152K 1.17% 25
2023
Q1
$2.39M Buy
+157,225
New +$2.05M 0.73% 36

Other funds holding ETNB

Tri Locum Partners's ETNB Position: Q4 2023 in Review

Tri Locum Partners sold out of 89bio (ETNB) in Q4 2023, closing a stake of 249,571 shares — an estimated $3.85M sold.

Tri Locum Partners first reported a position in ETNB in Q1 2023 and held it in 3 quarters. The position peaked at $3.85M in Q3 2023. 153 funds tracked by Wall St. Rank hold ETNB as of Q4 2023.

  • Tri Locum Partners reported no remaining 89bio position as of Q4 2023 after selling out during the quarter.
  • Tri Locum Partners sold 249,571 89bio shares in Q4 2023, an estimated $3.85M.
  • Tri Locum Partners first reported a position in 89bio in Q1 2023 and held it in 3 quarters.
  • Tri Locum Partners's 89bio position peaked at $3.85M in Q3 2023.
  • 153 funds tracked by Wall St. Rank held 89bio as of Q4 2023.

Based on Tri Locum Partners's 13F filing for Q4 2023, filed 14 Feb 2024.